| 标题 |
 Safety and activity of tarlatamab in combination with a PD-L1 inhibitor as first-line maintenance therapy after chemo-immunotherapy in patients with extensive-stage small-cell lung cancer (DeLLphi-303): a multicentre, non-randomised, phase 1b study |
| 网址 | |
| DOI | |
| 求助人 | |
| 下载 | 求助已完成，仅限求助人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)
Copyright
无极微光
cdercder
yjh123
Kao
Nexus
伶俐妙海
OK
Criminology34
Nole
小花
arniu2008
liuzhuohao
keven
初景
sagitar
huang
乐空思
lizishu
pluto
皖公网安备34019202002308
